Novo Nordisk shares plunge 26% after naming new CEO, cutting full-year guidance
Danish pharmaceutical giant Novo Nordisk on Tuesday cuts its full-year sales and profit guidance.
0 Comments
Danish pharmaceutical giant Novo Nordisk on Tuesday cuts its full-year sales and profit guidance.
Comments 0
No comments yet. Be the first to comment!